Bevacizumab Bombs Again in the BETH Breast Cancer StudyBevacizumab Bombs Again in the BETH Breast Cancer Study

With 2 different chemotherapy regimens, the addition of bevacizumab added no benefit and more adverse events. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news